Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
This article reviews the importance of patient education in patients with advanced NSCLC treated with immunotherapy. In addition, expert perspectives on patient education will be provided by Marianne Davies, DNP, ACNP, AOCNP, FAAN, an associate professor at Yale University, New Haven, CT, and a thoracic oncology nurse practitioner at the Smilow Cancer Hospital, Yale Comprehensive Cancer Center; and Shawn Perkins, RN, BSN, OCN, a nurse navigator from UNC Cancer Hospital, Chapel Hill, NC, who has lung cancer navigation experience in a community setting.
Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma: Focus on the Key Manifestations, Risk Stratification, and Management Patterns
ASK THE EXPERT: First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma